Watchlist Price Alert

Eiger BioPharmaceuticals ... (EIGR)

NASDAQ: EIGR · Real-Time Price · USD

1.73

0.00 (0.29%)

At close: Apr 03, 2024, 3:59 PM

Eiger BioPharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-74.96M	-96.78M	-33.92M	-65.05M	-70.25M	-52.39M	-42.45M	-47.09M
Depreciation & Amortization	750K	842K	799K	645K	486K	54K	41K	23K
Stock-Based Compensation	5.01M	8.32M	7.9M	5.97M	5.68M	5.01M	4.24M	3.19M
Other Working Capital	-608K	-132K	425K	-4M	-593K	1.42M	-865K	1.02M
Other Non-Cash Items	390K	4.13M	713K	1.02M	949K	1.02M	366K	4.06M
Deferred Income Tax	n/a	n/a	-45.5M	124K	-467K	-426K	-253K	124K
Change in Working Capital	-5.73M	481K	-1.34M	-5.9M	-9K	4.07M	-321K	1.72M
Operating Cash Flow	-74.55M	-83.01M	-71.34M	-63.19M	-63.61M	-42.67M	-38.37M	-37.97M
Capital Expenditures	-234K	-340K	-48.73M	-258K	-475K	-142K	-44K	-58K
Cash Acquisitions	n/a	-9.97M	46.49M	44.53M	16M	n/a	n/a	28.02M
Purchase of Investments	-19.39M	-75.1M	-84.65M	-128.29M	-96.27M	-57.19M	-24.52M	-34.15M
Sales Maturities Of Investments	93.85M	85.07M	99.63M	83.77M	80.27M	28.25M	47.02M	2M
Other Investing Acitivies	n/a	9.97M	48.79M	-44.53M	-16M	-28.94M	200K	28.02M
Investing Cash Flow	74.23M	9.63M	61.53M	-44.79M	-16.47M	-29.09M	22.66M	-4.19M
Debt Repayment	n/a	6.56M	n/a	n/a	4.96M	9.94M	n/a	14.76M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	41K	-1.01M	127K	684K	42K	406K	194K	46K
Financial Cash Flow	41K	76.95M	3.34M	97.46M	58.2M	100.98M	19.99M	65.14M
Net Cash Flow	-358K	3.58M	-6.64M	-10.51M	-21.89M	29.23M	4.28M	22.98M
Free Cash Flow	-74.78M	-83.35M	-120.07M	-63.44M	-64.09M	-42.81M	-38.42M	-38.03M